India’s OTC Potential, Regulatory Framework Entice Boehringer Ingelheim
This article was originally published in The Tan Sheet
Executive Summary
The family-controlled German drug maker is preparing an entry into the Indian consumer health care segment, a market seeing a flurry of activity from competitors including GSK and Sanofi.